Company / Current Liabilities
Structure Therapeutics Inc. Current Liabilities History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$63.3M
FY2025
5-year range
$13.0M / $63.3M
FY2022-FY2025
Trend
+75.7%
vs FY2024
Sector context
#126 of 213
Health Care
What the data says
At $63M, Structure Therapeutics Inc.'s current liabilities ranks #88 of 213 in the Health Care sector. Current Liabilities has increased for 3 consecutive years, from $13M in FY2022 to $63M in FY2025.
Based on SEC 10-K filings.
$63M in FY2025 with a 3-year CAGR of +69.4%.
Increased from $25M to $63M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +69.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#88 of 213 in Health CareTop 41% of 213This company $63.3M Sector average $1.6B
▼
-96.0% below sector average
Key checks
Key Insights
- Structure Therapeutics Inc.'s current liabilities has grown for 3 consecutive years.
- 3-year CAGR of +69.4%, indicating consistent growth.
- In FY2025, current liabilities increased 75.7% year-over-year.
- Ranks #126 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 9.77 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $63.3M | +75.7% |
| FY2024 | $36.0M | +45.6% |
| FY2023 | $24.7M | +90.2% |
| FY2022 | $13.0M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026